Keywords: Merck & Co, Headquarters move, Cost-saving, Vaxxas, Nanopatch, Vaccines

Merck & Co to move HQ as part of cost-savings plan; enters deal with Vaxxas

Article | 10 October 2012

Print This

US pharma giant Merck & Co (NYSE: MRK) is joining a string of drug majors in announcing cost-cutting moves in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in